Skip to main content
Equibles
VATE logo

VATE · INNOVATE Corp. · Webcasts, Transcripts & Audio

Track VATE — free

Use VATE with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research VATE.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$7.44 -0.06 (-0.80%) At close · Oct 5
Russell 2000 member Rebalance outlook locked
Going-concern doubt — flagged Aug 6, 2026

Substantial doubt about the company's ability to continue as a going concern.

“The accompanying unaudited Condensed Consolidated Financial Statements have been prepared assuming that the Company will continue as a going concern. However, as of the date of these financial statements, there is substantial doubt about the Company's ability to continue as a going concern within one year after the date that the financial statements are issued.”
View the 10-Q filed Aug 6, 2026
Market Cap
$106.00M
Shares
13.64M
Volume · Oct 5 57.66K Avg daily vol (3M) 379.66K

INNOVATE Corp. Webcasts

Earnings calls, investor updates, investor days and conferences for INNOVATE Corp. (VATE), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲7.1% $423.00M −$5.40M '22 Q3 22-11-02 ▲3.7% $409.30M −$5.70M '22 Q4 23-03-14 ▼23% $317.90M −$9.00M '23 Q1 23-05-10 ▼6% $368.80M −$9.90M '23 Q2 23-08-09 ▼11.3% $375.30M −$7.00M '23 Q3 23-11-09 ▼11.8% $361.00M −$9.30M '23 Q4 24-03-04 ▼0.8% $315.20M −$17.40M '24 Q1 24-05-07 ▼15.1% $313.10M $14.40M '24 Q2 24-08-07 ▼35.5% $242.20M −$15.00M '24 Q3 24-11-06 ▼34.5% $236.60M −$16.60M '24 Q4 25-03-31 ▼13% $274.20M −$24.50M '25 Q1 25-05-06 ▼22.7% $242.00M −$19.80M '25 Q2 25-08-05 ▲43.3% $347.10M −$8.90M '25 Q3 25-11-12 ▲61.7% $382.70M −$7.40M '25 Q4 26-03-26 ▲33% $364.80M −$16.80M '26 Q1 26-05-14 LATEST ▲74.2% $421.60M $10.70M '26 Q2 26-08-06
Earnings call
FY26 · Q2
2026-08-06
INNOVATE Corp. (VATE) Q2 2026 Earnings Call Transcript
Positive tone Life Sciences / MediBeacon commercialization Infrastructure / DBMG performance Broadcasting refinancing and sale
Revenue
$421.60M
▲ 74.2% YoY
Diluted EPS
$0.71
Gross margin
18.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-14
INNOVATE Corp. (VATE) Q1 2026 Earnings Call Transcript
Positive tone Infrastructure / DBM Global Backlog and Execution R2 Global Demand and Capital Needs MediBeacon Regulatory and Clinical Progress
Revenue
$364.80M
▲ 33% YoY
Diluted EPS
$-1.29
Gross margin
14.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-26
INNOVATE Corp. (VATE) Q4 2025 Earnings Call Transcript
Cautious tone MetaBeacon life sciences commercialization Spectrum segment advertising weakness and FCC opportunities Capital structure and debt
Revenue
$382.70M*
▲ 61.7% YoY
Gross margin
15.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-12
INNOVATE Corp. (VATE) Q3 2025 Earnings Call Transcript
Positive tone DBM Global backlog and project awards Strategic alternatives and divestitures Capital structure, debt and liquidity
Revenue
$347.10M
▲ 43.3% YoY
Diluted EPS
$-0.71
Gross margin
14.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-05
INNOVATE Corp. (VATE) Q2 2025 Earnings Call Transcript
Positive tone R2/Glacial Skin growth Refinancing and debt management Infrastructure/DBM Global backlog and margins
Revenue
$242.00M
▼ 22.7% YoY
Diluted EPS
$-1.67
▼ 262.1% YoY
Gross margin
18.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-06
INNOVATE Corp. (VATE) Q1 2025 Earnings Call Transcript
Positive tone Revenue decline and net loss DBM Global / Infrastructure backlog and margins Liquidity and cash decline
Revenue
$274.20M
▼ 13% YoY
Diluted EPS
$-1.89
Gross margin
16.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-31
INNOVATE Corp. (VATE) Q4 2024 Earnings Call
Revenue
$236.60M*
▼ 34.5% YoY
Gross margin
19.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-06
INNOVATE Corp. (VATE) Q3 2024 Earnings Call Transcript
Positive tone DBM Global / Infrastructure results Spectrum profitability improvement R2 / Glacial Life Sciences growth
Revenue
$242.20M
▼ 35.5% YoY
Diluted EPS
$-1.18
Gross margin
19.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-07
INNOVATE Corp. (VATE) Q2 2024 Earnings Call Transcript
Positive tone DBMG backlog and bidding MediBeacon FDA review Capital structure and refinancing
Revenue
$313.10M
▼ 15.1% YoY
Diluted EPS
$1.03
Gross margin
21.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
INNOVATE Corp. (VATE) Q1 2024 Earnings Call Transcript
Positive tone Infrastructure / DBM Global performance MediBeacon FDA approval process Spectrum Networks and broadcasting
Revenue
$315.20M
▼ 0.8% YoY
Diluted EPS
$-2.21
Gross margin
15.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-04
INNOVATE Corp. (VATE) Q4 2023 Earnings Call Transcript
Positive tone DBM Global / Infrastructure backlog and outlook MediBeacon FDA review Capital structure and liquidity
Revenue
$361.00M*
▼ 11.8% YoY
Gross margin
16.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-09
INNOVATE Corp. (VATE) Q3 2023 Earnings Call Transcript
Revenue
$375.30M
▼ 11.3% YoY
Diluted EPS
$-0.93
Gross margin
15.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-09
INNOVATE Corp. (VATE) Q2 2023 Earnings Call Transcript
Revenue
$368.80M
▼ 6% YoY
Diluted EPS
$-1.30
Gross margin
14.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-10
INNOVATE Corp. (VATE) Q1 2023 Earnings Call Transcript
Revenue
$317.90M
▼ 23% YoY
Diluted EPS
$-1.30
Gross margin
13.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-14
INNOVATE Corp. (VATE) Q4 2022 Earnings Call Transcript
Revenue
$409.30M*
▲ 3.7% YoY
Gross margin
15.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-02
INNOVATE Corp. (VATE) Q3 2022 Earnings Call Transcript
Revenue
$423.00M
▲ 7.1% YoY
Diluted EPS
$-0.90
Gross margin
13.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-03
INNOVATE Corp. (VATE) Q2 2022 Earnings Call Transcript
Revenue
$392.20M
▲ 60.9% YoY
Diluted EPS
$-1.80
Gross margin
12.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-04
INNOVATE Corp. (VATE) Q1 2022 Earnings Call Transcript
Revenue
$412.80M
▲ 140.3% YoY
Diluted EPS
$-1.80
▼ 220% YoY
Gross margin
12.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-09
INNOVATE Corp. (VATE) Q4 2021 Earnings Call Transcript
Revenue
$394.80M*
▲ 121.8% YoY
Gross margin
15.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-04
INNOVATE Corp. (VATE) Q3 2021 Earnings Call Transcript
Revenue
$394.80M
▲ 131.6% YoY
Diluted EPS
$-27.50
Gross margin
14.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-06
INNOVATE Corp. (VATE) Q2 2021 Earnings Call Transcript
Revenue
$243.80M
▲ 34.1% YoY
Diluted EPS
$-3.10
▼ 224% YoY
Gross margin
14.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-07
INNOVATE Corp. (VATE) Q1 2021 Earnings Call Transcript
Revenue
$171.80M
▼ 7.9% YoY
Diluted EPS
$1.50
Gross margin
17.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-10
INNOVATE Corp. (VATE) Q4 2020 Earnings Call Transcript
Revenue
$178.00M*
Gross margin
20.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-09
INNOVATE Corp. (VATE) Q3 2020 Earnings Call Transcript
Revenue
$170.50M
▼ 60.1% YoY
Diluted EPS
$-3.70
Gross margin
18.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-10
INNOVATE Corp. (VATE) Q2 2020 Earnings Call Transcript
Revenue
$181.80M
▼ 62.1% YoY
Diluted EPS
$2.50
▲ 108.3% YoY
Gross margin
16.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-11
INNOVATE Corp. (VATE) Q1 2020 Earnings Call Transcript
Revenue
$186.60M
▼ 58.4% YoY
Diluted EPS
$-18.20
Gross margin
16.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-03-16
INNOVATE Corp. (VATE) Q4 2019 Earnings Call
Revenue
$*
▼ 153.1% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–27 of 27 webcasts
Key facts CIK 1006837 CUSIP 45784J303 13F (30d) 1 filings 1 filers Visit website Investor relations